Tiny study uses special tracers to uncover Obesity's metabolic secrets

NCT ID NCT07020741

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will use special 'tracer' molecules (stable isotopes) to measure how the body of an adult with obesity processes protein and sugar. Eight participants will each undergo two test sessions: one measuring protein breakdown and another measuring glucose tolerance. The goal is to better understand the metabolic changes linked to obesity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stable isotope tracers (carbon-13 and deuterium-labeled glucose and phenylalanine)
What this could lead to
If successful, this study could help researchers better understand how obesity alters protein and sugar processing in the body, potentially guiding future treatments.
What could go wrong
This is a very small, early-stage observational study with only 8 participants. It is not testing a treatment, so it will not directly lead to a new therapy. Results may not apply to all people with obesity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Freer Hall - University of Illinois

    RECRUITING

    Urbana, Illinois, 61801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.